Bluebonnet

L-Glutamine 500 mg

D
N+ Score64
ProteinServing: 1 Capsule(s)Type: Amino acid/Protein [A1305]

Bluebonnet L-Glutamine 500 mg is an amino acid supplement, categorized under Protein, designed to provide a single active ingredient. This product contains 500 mg of L-Glutamine per serving, which is considered to be at a clinically studied dose for certain applications. With a total of 1 ingredient, the label offers full transparency, contributing to its N+ Score of 64 and a grade of D. While the ingredient adequacy is 100% for the included amino acid, its formula completeness is 0% due to its single-ingredient nature. This supplement may be suitable for individuals seeking a specific, isolated L-Glutamine supplement.

About This Product

L-Glutamine 500 mg by Bluebonnet is a protein supplement containing 1 active ingredients. It has earned an N+ Score of 64/100 (Grade D).

This product features a fully transparent label with individual ingredient amounts disclosed, and key ingredients are present at clinically effective doses based on peer-reviewed research.

Notable clinical-dose ingredients include L-Glutamine.

N+ Score Breakdown

Ingredient Adequacy100/100

Are key ingredients present at clinically effective doses based on research?

Formula Completeness0/100

Does the product include all expected ingredients for its supplement category?

Label Transparency100/100

Are individual ingredient amounts clearly disclosed without proprietary blends?

Ingredient Diversity44/100

Does the formula include a breadth of beneficial compounds from multiple pathways?

Strengths

  • +Key ingredients at clinically effective doses
  • +Fully transparent label with individual ingredient amounts disclosed
  • +1 ingredient(s) at clinical dose levels

Weaknesses

  • Missing several expected ingredients for its category

Ingredient Analysis (1 ingredients)

IngredientAmountDose Adequacy
L-Glutamine500.000 mgHigh

Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.